These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11072144)

  • 1. Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers.
    Yu YW; Lin CH; Chen SP; Hong CJ; Tsai SJ
    Neurosci Lett; 2000 Nov; 294(3):179-81. PubMed ID: 11072144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
    Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
    Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):284-9. PubMed ID: 14688411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality traits in young female apolipoprotein E (apoE) epsilon4 and non-epsilon4 carriers.
    Tsai SJ; Yu YW; Hong CJ
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):58-60. PubMed ID: 14681915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
    Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
    Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S;
    Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.
    Alexopoulos P; Richter-Schmidinger T; Horn M; Maus S; Reichel M; Sidiropoulos C; Rhein C; Lewczuk P; Doerfler A; Kornhuber J
    J Alzheimers Dis; 2011; 26(2):207-10. PubMed ID: 21606569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.
    Holmes C; Levy R; McLoughlin DM; Powell JF; Lovestone S
    J Neurol Neurosurg Psychiatry; 1996 Dec; 61(6):580-3. PubMed ID: 8971103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein ε4 is associated with better cognitive control allocation in healthy young adults.
    Zink N; Bensmann W; Arning L; Beste C; Stock AK
    Neuroimage; 2019 Jan; 185():274-285. PubMed ID: 30342978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gender difference in the association between APOE genotype and age-related cognitive decline.
    Mortensen EL; Høgh P
    Neurology; 2001 Jul; 57(1):89-95. PubMed ID: 11445633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE genotype and abnormal auditory cortical potentials in healthy older females.
    Irimajiri R; Golob EJ; Starr A
    Neurobiol Aging; 2010 Oct; 31(10):1799-804. PubMed ID: 18976833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical Functional Connections and Fluid Intelligence in Adolescent APOE ε4 Carriers.
    Woo M; Kim Y
    Dement Geriatr Cogn Disord; 2017; 44(3-4):153-159. PubMed ID: 28848214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
    Mielke R; Zerres K; Uhlhaas S; Kessler J; Heiss WD
    Neurosci Lett; 1998 Sep; 254(1):49-52. PubMed ID: 9780089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.